Skip header and navigation

Refine By

722 records – page 1 of 73.

Source
CANNT J. 2013 Apr-Jun;23(2):59-60
Publication Type
Article

[7 years of wandering within the justice machinery].

https://arctichealth.org/en/permalink/ahliterature227825
Source
Vardfacket. 1990 Dec 13;14(21):12
Publication Type
Article
Date
Dec-13-1990
Author
U. Jacobsson
Source
Vardfacket. 1990 Dec 13;14(21):12
Date
Dec-13-1990
Language
Swedish
Publication Type
Article
Keywords
Humans
Jurisprudence
Nursing Care - standards
Renal Dialysis - adverse effects
Sweden
PubMed ID
2096553 View in PubMed
Less detail

The 1994 annual report of the North American Pediatric Renal Transplant Cooperative Study.

https://arctichealth.org/en/permalink/ahliterature211369
Source
Pediatr Nephrol. 1996 Aug;10(4):422-34
Publication Type
Article
Date
Aug-1996
Author
E C Kohaut
A. Tejani
Author Affiliation
University of Alabama, Birmingham, USA.
Source
Pediatr Nephrol. 1996 Aug;10(4):422-34
Date
Aug-1996
Language
English
Publication Type
Article
Keywords
Adolescent
Annual Reports as Topic
Canada - epidemiology
Child
Child, Preschool
Female
Graft Rejection - prevention & control
Humans
Immunosuppressive Agents - therapeutic use
Infant
Kidney Failure, Chronic - mortality - surgery
Kidney Transplantation - utilization
Male
Renal Dialysis
United States - epidemiology
Abstract
The North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) is a research effort that was organized and initiated in 1987. The following manuscript is the 1994 NAPRTCS annual report which has summarized data that has been voluntarily contributed by 83 centers. The report includes data on 3,183 patients who have undergone a total of 3,445 renal transplants between 1 January 1987 and 18 February 1994 when the data set was closed. The report also contains data on 1,611 independent courses of dialysis which were initiated between 1 January 1992 and 18 February 1994. This report is meant to update the previous NAPRTCS annual reports as well as demonstrate how the NAPRTCS database has changed clinical practice since its inception. There have been 855 graft failures among the 3,438 transplants. Due to the maturing of the database, chronic rejection now accounts for 34% of graft failures which have occurred over the last year. Graft failure was increased in recipients if the recipients were 6 years did not have catch-up growth post transplant. Overall graft survival has improved markedly since the inception of this study. The dialysis database is just maturing and the data confirm that growth on dialysis continues to be very poor. The 1994 annual report of NAPRTCS extends previous findings of this valuable database. It is gratifying to know that early findings of NAPRTCS have led to changes in therapy which have led to improvement in the care of these very special children.
PubMed ID
8865236 View in PubMed
Less detail

Abdominal Aortic Calcifications Predict Survival in Peritoneal Dialysis Patients.

https://arctichealth.org/en/permalink/ahliterature298110
Source
Perit Dial Int. 2018 Sep-Oct; 38(5):366-373
Publication Type
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Author
Satu Mäkelä
Markku Asola
Henrik Hadimeri
James Heaf
Maija Heiro
Leena Kauppila
Susanne Ljungman
Mai Ots-Rosenberg
Johan V Povlsen
Björn Rogland
Petra Roessel
Jana Uhlinova
Maarit Vainiotalo
Maria K Svensson
Heini Huhtala
Heikki Saha
Author Affiliation
Tampere University Hospital, Tampere, Finland satu.m.makela@pshp.fi.
Source
Perit Dial Int. 2018 Sep-Oct; 38(5):366-373
Language
English
Publication Type
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Keywords
Ankle Brachial Index
Aorta, Abdominal - diagnostic imaging
Aortic Diseases - diagnosis - epidemiology - etiology
Cause of Death - trends
Critical Illness - mortality - therapy
Denmark - epidemiology
Estonia - epidemiology
Female
Finland - epidemiology
Humans
Incidence
Male
Middle Aged
Peritoneal Dialysis - adverse effects - mortality
Prognosis
Prospective Studies
Renal Dialysis
Risk factors
Survival Rate - trends
Sweden - epidemiology
Ultrasonography, Doppler
Vascular Calcification - diagnosis - epidemiology - etiology
Abstract
Peripheral arterial disease and vascular calcifications contribute significantly to the outcome of dialysis patients. The aim of this study was to evaluate the prognostic role of severity of abdominal aortic calcifications and peripheral arterial disease on outcome of peritoneal dialysis (PD) patients using methods easily available in everyday clinical practice.
We enrolled 249 PD patients (mean age 61 years, 67% male) in this prospective, observational, multicenter study from 2009 to 2013. The abdominal aortic calcification score (AACS) was assessed using lateral lumbar X ray, and the ankle-brachial index (ABI) using a Doppler device.
The median AACS was 11 (range 0 - 24). In 58% of the patients, all 4 segments of the abdominal aorta showed deposits, while 19% of patients had no visible deposits (AACS 0). Ankle-brachial index was normal in 49%, low ( 1.3) in 34% of patients. Altogether 91 patients (37%) died during the median follow-up of 46 months. Only 2 patients (5%) with AACS 0 died compared with 50% of the patients with AACS = 7 (p
PubMed ID
29386304 View in PubMed
Less detail

Access to new drugs for dialysis patients: challenges for indigenous and non-indigenous populations.

https://arctichealth.org/en/permalink/ahliterature139778
Source
Clin Nephrol. 2010 Nov;74 Suppl 1:S138-41
Publication Type
Article
Date
Nov-2010
Author
D C Mendelssohn
Author Affiliation
Humber River Regional Hospital and University of Toronto, Toronto, Canada. dmendelssohn@hrrh.on.ca
Source
Clin Nephrol. 2010 Nov;74 Suppl 1:S138-41
Date
Nov-2010
Language
English
Publication Type
Article
Keywords
Canada
Comparative Effectiveness Research
Drug Evaluation - methods
Evidence-Based Medicine
Health Services Accessibility
Humans
Kidney Failure, Chronic - drug therapy
Medical Indigency
Patient Advocacy
Pharmaceutical Preparations - economics - supply & distribution
Renal Dialysis
Abstract
Most dialysis patients are on 5 - 10 medications. The costs of these medications vary widely, ranging from pennies per day for water soluble multivitamins, to several thousand dollars per year for erythropoietin-stimulating agents. In Canada, public funding for drug therapies is undertaken by each province, with wide variability in coverage and on restriction criteria for expensive new drugs. For native Canadians and Inuit, access to drugs is superior to that of other Canadians through a federal program. The Canadian system for drug evaluation, where strict evidence-based medicine (EBM) and comparative effectiveness research (CER) is applied, is instructive and may provide clues to the future from an international perspective. Given the unique challenges in nephrology, it is predicted that access to new drugs and other therapies will be restricted by these evaluation methods. Indeed, it seems desirable for nephrology organizations to respond to this new threat in a pragmatic and balanced way. Part of that response might be a call for exceptional status for dialysis, with adjusted criteria of EBM and CER that would be more suitable, and stimulate innovation and research in nephrology.
PubMed ID
20979980 View in PubMed
Less detail

Achievement of recommended treatment targets for bone and mineral metabolism in haemodialysis patients using paricalcitol: an observational study.

https://arctichealth.org/en/permalink/ahliterature136584
Source
Scand J Urol Nephrol. 2011 Apr;45(3):196-205
Publication Type
Article
Date
Apr-2011
Author
Anders Fernström
Jan Giæver
Barbara Granroth
Britta Hylander
Gert Jensen
Anders Christensson
Björn Wikström
Lars Weiss
Ulf Wrege
Stefan H Jacobson
Author Affiliation
Department of Nephrology, Linköping University/Linköping University Hospital, Linköping, Sweden. anders.fernstrom@lio.se
Source
Scand J Urol Nephrol. 2011 Apr;45(3):196-205
Date
Apr-2011
Language
English
Publication Type
Article
Keywords
Aged
Biomarkers, Pharmacological - blood - metabolism
Bone Density - drug effects
Bone Density Conservation Agents - administration & dosage - pharmacology - therapeutic use
Bone Diseases, Metabolic - drug therapy - etiology - metabolism
Bone and Bones - metabolism
Calcium - blood
Chronic Disease
Ergocalciferols - administration & dosage - pharmacology - therapeutic use
Female
Humans
Hyperparathyroidism, Secondary - complications - drug therapy - metabolism
Injections, Intravenous
Kidney Diseases - complications - metabolism - therapy
Male
Middle Aged
Observation
Parathyroid Hormone - metabolism
Phosphorus - blood
Prospective Studies
Renal Dialysis
Sweden
Abstract
Secondary hyperparathyroidism (SHPT) is a common problem among patients with chronic kidney disease (CKD) on haemodialysis. This study was conducted to assess the use, effectiveness and safety of intravenous paricalcitol in haemodialysis patients with various degrees of SHPT.
This observational, multicentre, prospective study was conducted in 14 Swedish dialysis centres from May 2007 to June 2008 and included 92 haemodialysis patients with a diagnosis of SHPT associated with CKD. The decision to initiate treatment with intravenous paricalcitol was made by the treating physician. No treatment algorithms were provided.
Mean patient age was 64 years. Of the 92 patients included, 74 had an intact parathyroid hormone (iPTH) level of >300 pg/ml at baseline. Median iPTH was 584 pg/ml in patients with a baseline PTH of >300 pg/ml. During follow-up there was a decrease in iPTH to 323 pg/ml at 6 months (-45%, p
PubMed ID
21366390 View in PubMed
Less detail

[A clinic for prevention of progression of kidney failure].

https://arctichealth.org/en/permalink/ahliterature164390
Source
J Ren Care. 2006 Jul-Sep;32(3):153-6
Publication Type
Article
Author
A. Brousseau
Author Affiliation
Centre Hospitalier Ambulatoire Régionale de Laval, Québec, Kanada. abrousse_charl@ssss.gouv.qc.ca
Source
J Ren Care. 2006 Jul-Sep;32(3):153-6
Language
German
Publication Type
Article
Keywords
Adolescent
Adult
Aged
Albuminuria - diagnosis - prevention & control
Body mass index
Canada - epidemiology
Disease Progression
Exercise
Female
Follow-Up Studies
Glomerular Filtration Rate
Humans
Hypertension - epidemiology - prevention & control
Kidney Failure, Chronic - diagnosis - epidemiology - prevention & control - therapy
Male
Middle Aged
Outpatient Clinics, Hospital
Patient care team
Patient Education as Topic
Peritoneal dialysis
Primary Prevention
Quebec
Renal Dialysis
Smoking Cessation
Time Factors
Abstract
Prevention in nephrology is only possible with the cooperation of patients and their families. The nurse plays a considerable role in working with patients and is a major player in the team, responsible for follow-up of the patient, where the earliest interventions can help delay and sometimes avoid dialysis. The hypertension clinic is the beginning of a continuum until dialysis. This paper describes three clinics that are managed in the renal service and indicates how they contribute to offering optimal care to a renal population.
PubMed ID
17393810 View in PubMed
Less detail

[Active treatment of uremia in the study county of Vejle. Epidemiology 1979-1994 and future perspectives]

https://arctichealth.org/en/permalink/ahliterature34751
Source
Ugeskr Laeger. 1996 Jun 24;158(26):3759-63
Publication Type
Article
Date
Jun-24-1996
Author
P. Vestergaard
A. Frøland
J H Kristiansen
Author Affiliation
Medicinsk afdeling, Fredericia Sygehus.
Source
Ugeskr Laeger. 1996 Jun 24;158(26):3759-63
Date
Jun-24-1996
Language
Danish
Publication Type
Article
Keywords
Adolescent
Adult
Aged
Child
Denmark - epidemiology
English Abstract
Female
Forecasting
Humans
Incidence
Kidney Failure, Chronic - epidemiology - surgery - therapy
Kidney Transplantation - statistics & numerical data - trends
Male
Middle Aged
Peritoneal Dialysis - statistics & numerical data - trends
Peritoneal Dialysis, Continuous Ambulatory - statistics & numerical data - trends
Prevalence
Prospective Studies
Renal Dialysis - statistics & numerical data - trends
Uremia - epidemiology - surgery - therapy
Abstract
We studied 275 renal replacement therapy (RRT) patients in a Danish county (population 329,000) from January 1st 1979 to June 30th 1994. Incidence, prevalence and age of new patients increased. The fraction of patients with diabetic nephropathy also increased. Patient survival remained constant (five-year survival 62% for patients observed for more than 90 days). The total number of new patients entering haemodialysis and peritoneal dialysis seemed to be reaching a constant level, that could be calculated using a logistic function. The fraction of patients leaving therapy remained constant over the years and was higher for peritoneal dialysis than for haemodialysis (32 vs. 20% per year). The future prevalence can be estimated by combining these two last findings.
Notes
Comment In: Ugeskr Laeger. 1996 Sep 2;158(36):5044-58928247
PubMed ID
8686069 View in PubMed
Less detail

722 records – page 1 of 73.